Effect of cyclodextrins on the hydrolysis of an oxazolidine prodrug of (1R,2S)-(-)-ephedrine-cis-2-(4-methoxyphenyl)-3,4-dimethyl-5-phenyloxazolidin e

Rapid Communications in Mass Spectrometry

Volumn 11, Issue 6, 1997, Pages 598-602

  Bakhtiar, R ^a   Hop, C E C A ^a   Walker, R B ^b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF ARKANSAS AT PINE BLUFF   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG PRODUCTS; HYDROLYSIS; MASS SPECTROMETRY;

EXPERIMENTAL CONDITIONS; INCLUSION COMPLEXATION; IONSPRAY; MOLECULAR COMPLEXES; OXAZOLIDINES; PRODRUGS; RATE OF HYDROLYSIS; RETARDATION EFFECT; STABILIZATION EFFECTS; STOICHIOMETRIC COMPLEXES;

CYCLODEXTRINS;

EID: 0030738760     PISSN: 09514198     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0231(199704)11:6<598::AID-RCM903>3.0.CO;2-V     Document Type: Article

References (52)

1. J. F. Wojcik, Bioorg. Chem. 12, 130 (1984).
2. T. Loftsson and M. E. Brewster, J. Pharm. Sci. 85, 1017 (1996).
3. R. A. Rajewski and V. J. Stella, J. Pharm. Sci. 85, 1142 (1996).
4. W. Saenger, Angew. Chem., Int. Ed. Engl. 19, 344 (1980).
5. S. D. Eastburn and B. Y. Tao, Biotechnol. Adv. 12, 325 (1994).
6. F. Shahidi and X-Q. Han, Crit. Rev. Food Sci. Nutr. 33, 501 (1993).
7. (a) R. Breslow, Acc. Chem. Res. 28, 146 (1995)
8. (b) R. Breslow, Pure Appl. Chem. 66, 1573 (1994).
9. R. B. Walker, V. Dholakia, J. R. Reed, L. B. Love, D. Ewing, R. Bakhtiar and B. Gurley, Pharm. Res. (Suppl.), 13(9), Abstract MNPC 5051, S-151 (1996).
10. B. B. Hoffman and R. J. Lefkowitz, in Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th edn., Chapt. 10. McGraw-Hill, New York (1996).
11. (a) R. B. Walker, L. D. Fitz, L. M. Williams and Y. M. McDaniel, Gen. Pharmacol 27, 109 (1996)
12. (b) R. B. Walker, L. D. Fitz, L. M. Williams, H. Linton, Jr, and C. C. Smith, Gen. Pharmacol. 24, 669 (1993)
13. (c) R. B. Walker, D. M. Wood and M. M. Akmal, Life Sci. 47, 595 (1990)
14. (d) R. B. Walker, M. Massey, D. M. Wood and M. M. Akmal, Drugs Future 17, 215 (1992), and references cited therein.
15. (a) A. S. Kearney, Adv. Drug Deliv. Rev. 19, 225 (1996)
16. (b) M. D. Taylor, Adv. Drug Deliv. Rev. 19, 131 (1996).
17. (a) P. Camilleri, N. J. Haskins, A. P. New and M. R. Saunders, Rapid Commun. Mass Spectrom. 7, 949 (1993)
18. (b) J. B. Cunniff and P. Vouros, J. Am. Soc. Mass Spectrom. 6, 437 (1995)
19. (c) R. L. Sheppard, X. Tong, J. Cai and J. D. Henion, Anal. Chem. 67, 2054 (1995)
20. (d) J. Lin, F. Djedaini-Pilard, P. Guenot and B. Perly, Supramol. Chem. 7, 175 (1996)
21. (e) E. Redenti, M. Pasini, P. Ventura, A. Spisni, M. Vikmon and J. Szejtli, J. Incl. Phenom. Mol. Recogn. Chem. 15, 281 (1993)
22. (f) V. Lemesle-Lamache, D. Wouessidjewe, M. Cheron and D. Duchene, Int. J. Pharm. 141, 117 (1996)
23. (g) P. Cescutti, D. Garozzo and R. Rizzo, Carbohydr. Res. 290, 105 (1996)
24. (h) B. Chankvetadze, G. Endresz, G. Blaschke, M. Juza, H. Jakubetz and V. Schurig, Carbohydr. Res. 287, 139 (1996)
25. (i) S. K Davey, D. A. Leigh, J. P. Smart, L. W. Tetler and A. M. Truscello, Carbohydr Res. 287, 139 (1996)
26. (j) E. Lamcharfi, S. Chuolin, A. Kerbal, G. Kunesch and F. Libot, J. Mass Spectrom. 31, 982 (1996)
27. (k) R. Ramanathan and L. Prokai, J. Am. Soc. Mass Spectrom. 6, 866 (1995)
28. (l) P. S. Bates, D. Parker and B. N. Green, Chem. Commun. 693 (1993)
29. (m) M. Vincenti, J. Mass Spectrom. 30, 925 (1995)
30. (n) R. Bakhtiar and S. Bulusu, Rapid Commun. Mass Spectrom. 9, 1391 (1995)
31. (o) A. Selva, E. Redenti, P. Ventura, M. Zanol and B. Casetta, J. Mass Spectrom. 31, 1364 (1996)
32. (p) K. Wang and G. W. Gokel, Pure Appl. Chem. 68, 1267 (1996)
33. (q) D. Parker and R. Kataky, Chem. Commun. 141 (1997).
34. (a) J. Henion, Y. T. Li, Y. L. Hsieh and B. Ganem, Ther. Drug Monit. 15, 563 (1993)
35. (b) B. Ganem, Am. Biotechnol. Lab. Sept., 32 (1993)
36. (c) Y. T. Li, Y. L. Hsieb, J. D. Henion, T. D. Ocain, G. A. Schiehser and B. Ganem, J. Am. Chem. Soc. 116, 7487 (1994)
37. (d) C. E. C. A. Hop and R. Bakhtiar, Biospectroscopy (in press).
38. (a) T. H. Fife and J. E. C. Hutchins, J. Org. Chem. 45, 2099 (1980)
39. (b) R. A. McClelland and R. Somani, J. Org. Chem. 46, 4345 (1981)
40. (c) M. Johansen and H. Bundgaard, J. Pharm. Sci. 72 1294 (1983).
41. (a) T. T. Ndou, S. Mukundan, Jr, and I. M. Warner, J. Inclus. Phenom. Mol. Recogn. Chem. 15, 9 (1993)
42. (b) M. V. Rekharsky, R. N. Goldberg, F. P. Schwarz, Y. B. Tewari, P. D. Ross, Y. Yamashoji and Y. Inoue, J. Am. Chem. Soc. 117, 8830 (1995).
43. A. K. Roy and J. K. Guillory, Int. J. Pharm. 138, 37 (1996).
44. M. Kamiya and K. Nakamura, Pestic. Sci 41, 305 (1994).
45. G. Blaschke, E. Lamparter and J. Schluter, Chirality 5, 78 (1993).
46. G. A. El-Gendy and M. A. El-Gendy, Eur. J. Pharm. Biopharm. 39, 249 (1993).
47. A. Granados and R. H. de Rossi, J. Org. Chem. 58, 1771 (1993).
48. M. Kamiya, S. Mitsuhashi and M. Makino, Chemosphere 25, 1783 (1992).
49. P. Jarho, A. Urtti and T. Jarvinen, Pharm. Res. 12, 1371 (1995).
50. V. J. Stella, H. K. Lee and D. O. Thompson, Int. J. Pharm. 120, 189, 197 (1995).
51. T. Beyrich and K. Kottke, Pharmazie 51, 36 (1996).
52. T. Shiraishi, M. Hiraiwa and Y. Uda, Glycoconj. J. 10, 170 (1993).